EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Chemo-omic pipeline enables discovery of prion synaptotoxic pathways and inhibitory drugs

Nhat T T Le, Robert C C Mercer iD, Cheng Fang, Aravind Sundaravadivelu, Adam T Labadorf, Weiwei Lin, Julian Kwan, Benjamin Blum, Andrew Emili, David A Harris iD

PLOS Pathogens · 2026

DOI: 10.1371/journal.ppat.1014314 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2026. Verfasst von Nhat T T Le und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Cell Biology, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts, United States of Am…. Hauptthemen laut MEDLINE: Prion Diseases, Synapses, Neurons, PrPSc Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NINDS NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prion propagation, in which the cellular prion protein (PrP C ) is conformationally converted into an infectious structure (PrP Sc ), has been extensively studied. However, the molecular mechanism responsible for the neurotoxicity of prions remains unclear. Synaptic loss is one of the earliest events in both in vivo and in vitro models of prion disease. We previously developed a neuronal cell culture model to analyze the mechanisms of prion-induced synaptic degeneration in a physiologically relevant setting. Using this system, we showed that exposure of hippocampal neurons to PrP Sc engages a NMDAR/p38 mitogen-activated protein kinase (MAPK) signaling pathway that results in rapid, PrP C -dependent loss of synaptic transmission and retraction of dendritic spines. To comprehensively identify the components of this synaptotoxic signaling pathway, we measured changes in the phosphoproteome and transcriptome of hippocampal neurons exposed to PrP Sc while they were undergoing the process of dendritic spine retraction. We then used these data as input into the L1000 and P100 databases of transcriptomic and proteomic drug signatures, leading to the discovery of 17 compounds that were able to prevent PrP Sc -induced spine retraction. These compounds converged on three protein kinase targets: Ca 2+ /calmodulin-dependent protein kinase II (CaMKII), protein kinase C (PKC), and glycogen synthase kinase 3β (GSK3β). Using immunocytochemical staining, we confirmed that PrP Sc treatment of hippocampal neurons induced phosphorylation of the three kinases and caused their rapid translocation to dendritic spines. Along with N-methyl-D-aspartate receptors (NMDARs) on the neuronal surface, which trigger an initial influx of Ca 2+ in response to PrP Sc , these kinases constitute key nodes in a signaling network that mediates prion synaptotoxicity. Taken together, our results provide new insights into the mechanisms of prion neurotoxicity, and they identify novel molecular targets and inhibitory compounds that can be utilized for therapy of prion diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prion DiseasesSynapsesNeuronsPrPSc ProteinsPrionsAnimalsHippocampusMiceSignal TransductionDendritic SpinesCells, CulturedProteomicsReceptors, N-Methyl-D-AspartateSynaptic Transmission

Substanzen

PrPSc ProteinsPrionsReceptors, N-Methyl-D-Aspartate

Autor:innen und Institutionen

  • Department of Biochemistry and Cell Biology, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts, United States of America.
  • Bioinformatics Program, Boston University, Boston, Massachusetts, United States of America.
  • Department of Pharmacology, Physiology and Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts, United States of America.

ORCID-Profile: Robert C C Mercer, David A Harris

Förderung

  • NIA NIH HHS
  • NINDS NIH HHS
  • National Institutes of Health
  • Warren Alpert Foundation

Zitieren

APA

Le, N. T. T., Mercer, R. C. C., Fang, C., Sundaravadivelu, A., Labadorf, A. T., Lin, W., Kwan, J., Blum, B., Emili, A., & Harris, D. A. (2026). Chemo-omic pipeline enables discovery of prion synaptotoxic pathways and inhibitory drugs. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1014314

Vancouver

Le NTT, Mercer RCC, Fang C, Sundaravadivelu A, Labadorf AT, Lin W, et al. Chemo-omic pipeline enables discovery of prion synaptotoxic pathways and inhibitory drugs. PLOS Pathogens. 2026. doi:10.1371/journal.ppat.1014314

BibTeX
@article{Le2026,
  author = {Le, Nhat T T and Mercer, Robert C C and Fang, Cheng and Sundaravadivelu, Aravind and Labadorf, Adam T and Lin, Weiwei and Kwan, Julian and Blum, Benjamin and Emili, Andrew and Harris, David A},
  title = {Chemo-omic pipeline enables discovery of prion synaptotoxic pathways and inhibitory drugs},
  journal = {PLOS Pathogens},
  year = {2026},
  doi = {10.1371/journal.ppat.1014314}
}
Kostenlos starten →